These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9461130)

  • 21. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis.
    Fujimoto M; Hamaguchi Y; Yazawa N; Komura K; Takehara K; Sato S
    Clin Exp Immunol; 2004 Dec; 138(3):534-9. PubMed ID: 15544633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC
    Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there any pathogenic role for the anti-endothelial cell antibodies (AECA) in autoimmune vasculitis?
    Meroni PL; Del Papa N; Raschi E; Panzeri P; Borghi MO
    J Biol Regul Homeost Agents; 1997; 11(4):127-32. PubMed ID: 9582611
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide.
    Marino M; Ruvo M; De Falco S; Fassina G
    Nat Biotechnol; 2000 Jul; 18(7):735-9. PubMed ID: 10888840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
    Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
    J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
    Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-alpha-inducible proteins are novel autoantigens in murine lupus.
    Hueber W; Zeng D; Strober S; Utz PJ
    Arthritis Rheum; 2004 Oct; 50(10):3239-49. PubMed ID: 15476221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
    Schaefer CJ; Wooley PH
    J Rheumatol; 1999 Oct; 26(10):2215-21. PubMed ID: 10529143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
    Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
    J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice.
    Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B
    J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 deficiency in murine systemic lupus erythematosus.
    Wofsy D; Dauphinée MJ; Kipper SB; Talal N
    Trans Assoc Am Physicians; 1981; 94():341-8. PubMed ID: 6979821
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changing concepts of disseminated lupus erythematosus].
    Tron F; Bach JF
    Nouv Presse Med; 1980 Sep; 9(33):2315-8. PubMed ID: 7433021
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation-induced cytidine deaminase catalytic domain as a target to eliminate pathogenic autoantibodies.
    Morel L
    Arthritis Rheum; 2011 Jul; 63(7):1776-8. PubMed ID: 21305518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.